Mail

UK markets close in 4 hours 36 minutes

FTSE 100
8,233.19
-20.99(-0.25%)
FTSE 250
20,588.06
-117.21(-0.57%)
AIM
805.16
-3.20(-0.40%)
GBP/EUR
1.1751
-0.0004(-0.04%)
GBP/USD
1.2749
-0.0023(-0.18%)
Bitcoin GBP
53,244.95
-490.81(-0.91%)

Should you support your children at university or help them on to property ladder?

What parents should consider before making a financial decision

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)

Shanghai - Shanghai Delayed price. Currency in CNY

Add to watchlist

43.02

-0.25

(-0.58%)

At close: 03:00PM CST

Currency in CNY

Valuation measures⁴

Market cap (intra-day)	276.02B
Enterprise value	254.33B
Trailing P/E	61.00
Forward P/E	59.52
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	11.58
Price/book (mrq)	6.50
Enterprise value/revenue	10.75
Enterprise value/EBITDA	51.82

Trading information

Stock price history

Beta (5Y monthly)	0.22
52-week change ³	-5.01%
S&P500 52-week change ³	26.94%
52-week high ³	50.50
52-week low ³	35.51
50-day moving average ³	44.97
200-day moving average ³	44.03

Share statistics

Avg vol (3-month) ³	28.24M
Avg vol (10-day) ³	27.63M
Shares outstanding ⁵	6.38B
Implied shares outstanding ⁶	6.69B
Float ⁸	3.5B
% held by insiders ¹	48.59%
% held by institutions ¹	16.61%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.16
Forward annual dividend yield ⁴	0.37%
Trailing annual dividend rate ³	0.20
Trailing annual dividend yield ³	0.46%
5-year average dividend yield ⁴	0.32
Payout ratio ⁴	22.86%
Dividend date ³	N/A
Ex-dividend date ⁴	08 Jun 2023
Last split factor ²	1.2:1
Last split date ³	10 Jun 2021

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	19.00%
Operating margin (ttm)	24.64%

Management effectiveness

Return on assets (ttm)	6.22%
Return on equity (ttm)	10.77%

Income statement

Revenue (ttm)	23.32B
Revenue per share (ttm)	3.69
Quarterly revenue growth (yoy)	9.20%
Gross profit (ttm)	N/A
EBITDA	5.09B
Net income avi to common (ttm)	4.43B
Diluted EPS (ttm)	0.71
Quarterly earnings growth (yoy)	10.50%

Balance sheet

Total cash (mrq)	21.77B
Total cash per share (mrq)	3.34
Total debt (mrq)	78.4M
Total debt/equity (mrq)	0.19%
Current ratio (mrq)	9.12
Book value per share (mrq)	6.42

Cash flow statement

Operating cash flow (ttm)	8.68B
Levered free cash flow (ttm)	5.96B